Disseminated coccidioidomycosis: Difference between revisions
Content deleted Content added
Included citation from article in medical journal documenting early treatment with amphotericin B in 1957. |
TurboSuperA+ (talk | contribs) restructured the text a bit and removed the copyedit notice |
||
| (8 intermediate revisions by 8 users not shown) | |||
| Line 25: | Line 25: | ||
}} |
}} |
||
'''Disseminated coccidioidomycosis''' is a systemic infection |
'''Disseminated coccidioidomycosis''' is a systemic infection caused by ''[[Coccidioides immitis]]''. 15-20% of people with the infection develop [[skin lesion]]s.<ref name="Andrews">{{cite book |author1=James, William D. |author2=Berger, Timothy G. |title=Andrews' Diseases of the Skin: Clinical Dermatology |publisher=Saunders Elsevier |year=2006 |isbn=0-7216-2921-0 |display-authors=etal}}</ref>{{rp|315}} <!-- Consider adding the page number below in the number 1 reference. --> |
||
== History of treatment == |
|||
| ⚫ | One of the earliest treatments for the disease was publicized in the ''New York State Journal of Medicine'' in 1959, in an article titled "Disseminated Coccidioidomycosis Treated with [[Amphotericin B]]". The case centered around a patient who was admitted to the U.S. Public Health Service Hospital in Seattle, Washington. Prior to the introduction of Amphotericin B, disseminated coccidioidomycosis had no specific chemotherapeutic treatment. Amphotericin B, a polyene antifungal antibiotic, was first trialed for this condition approximately three years earlier. Since then, multiple reports have highlighted the drug's clinical effectiveness in patients with coccidioidomycosis. <ref>{{Cite journal |last=La Barbera, M.D. |first=Salvatore A. |date=October 1, 1959 |title=Disseminated Coccidioidomycosis Treated with Amphotericin B |journal=New York State Journal of Medicine |volume=59 |issue=19 |pages=3644}}</ref> |
||
{{Mycoses}} |
|||
== See also == |
== See also == |
||
| Line 31: | Line 36: | ||
* [[List of cutaneous conditions]] |
* [[List of cutaneous conditions]] |
||
== References <!-- Should this References section be underneath the table? -->== |
|||
== References == |
|||
{{reflist}} |
{{reflist}} |
||
{{Mycoses}}'''History of Treatment''' |
|||
| ⚫ | |||
[[Category:Mycosis-related cutaneous conditions]] |
[[Category:Mycosis-related cutaneous conditions]] |
||
Latest revision as of 10:12, 26 December 2024
| Disseminated coccidioidomycosis | |
|---|---|
| Other names | Coccidioidal granuloma |
 | |
| Characteristic skin granulomata on the forehead. | |
| Specialty | Infectious diseases |
Disseminated coccidioidomycosis is a systemic infection caused by Coccidioides immitis. 15-20% of people with the infection develop skin lesions.[1]: 315
History of treatment
[edit]One of the earliest treatments for the disease was publicized in the New York State Journal of Medicine in 1959, in an article titled "Disseminated Coccidioidomycosis Treated with Amphotericin B". The case centered around a patient who was admitted to the U.S. Public Health Service Hospital in Seattle, Washington. Prior to the introduction of Amphotericin B, disseminated coccidioidomycosis had no specific chemotherapeutic treatment. Amphotericin B, a polyene antifungal antibiotic, was first trialed for this condition approximately three years earlier. Since then, multiple reports have highlighted the drug's clinical effectiveness in patients with coccidioidomycosis. [2]
See also
[edit]References
[edit]- ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: Clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
- ^ La Barbera, M.D., Salvatore A. (October 1, 1959). "Disseminated Coccidioidomycosis Treated with Amphotericin B". New York State Journal of Medicine. 59 (19): 3644.